tiprankstipranks
Trending News
More News >
Cyfuse Biomedical K.K. (JP:4892)
:4892
Japanese Market
Advertisement

Cyfuse Biomedical K.K. (4892) Income Statement

Compare
0 Followers

Cyfuse Biomedical K.K. Income Statement

Last quarter (Q4 2024), Cyfuse Biomedical K.K.'s total revenue was ¥28.00M, a decrease of -10.78% from the same quarter last year. In Q4, Cyfuse Biomedical K.K.'s net income was ¥-208.00M. See Cyfuse Biomedical K.K.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 54.45M¥ 61.11M¥ 374.48M¥ 708.25M¥ 137.48M
Gross Profit
¥ 16.45M¥ 37.74M¥ 241.50M¥ 570.60M¥ 67.02M
Operating Expenses
¥ 912.00M¥ 735.18M¥ 666.59M¥ 500.03M¥ 439.16M
Depreciation and Amortization
¥ 36.02M¥ 38.12M¥ 54.28M¥ 18.50M¥ 32.89M
EBITDA
¥ -824.22M¥ -538.29M¥ -410.21M¥ 168.65M¥ -288.66M
Operating Income
¥ -896.13M¥ -697.44M¥ -425.09M¥ 70.57M¥ -372.13M
Other Income/Expenses
¥ 26.39M¥ 111.25M¥ -46.86M¥ 74.34M¥ 44.64M
Pretax Income
¥ -869.75M¥ -586.19M¥ -471.95M¥ 144.91M¥ -327.49M
Net Income
¥ -872.24M¥ -589.21M¥ -473.96M¥ 142.91M¥ -329.50M
Per Share Metrics
Basic EPS
¥ -108.31¥ -75.42¥ -177.67¥ 285.52¥ -46.12
Diluted EPS
¥ -108.31¥ -75.42¥ -177.67¥ 285.52¥ -46.12
Weighted Average Shares Outstanding
8.05M 7.81M 2.67M 500.50K 7.14M
Weighted Average Shares Outstanding (Diluted)
8.05M 7.81M 2.67M 500.50K 7.14M
Currency in JPY

Cyfuse Biomedical K.K. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis